• Intravesical p21 mRNA–LNP Therapy for Bladder Cancer

  2026-08-28

  The reference study develops a nonviral, bladder-localized tumor suppressor replacement strategy using chemically modified CDKN1A/p21 mRNA in lipid nanoparticles. Its combination of localized expression, cell-cycle inhibition, DNA-damage signaling, and tumor suppression in an orthotopic model supports further investigation of intravesical mRNA delivery while leaving formulation-specific questions open.

• Patient-Derived Gastric Cancer Assembloids Explained

  2026-08-28

  This 2025 study develops patient-matched gastric cancer assembloids that combine tumor organoids with distinct stromal cell populations from the same specimen. The model captures microenvironment-dependent gene expression and drug-response heterogeneity, offering a more physiologically relevant framework for biomarker discovery, resistance studies, and personalized screening.

• Tofacitinib Repairs GM-CSF–Driven RA Macrophages

  2026-08-27

  The 2026 reference study shows that GM-CSF reprograms rheumatoid arthritis macrophages into an inflammatory, metabolically stressed state marked by oxidative damage and mitochondrial fragmentation. Tofacitinib reversed this phenotype more broadly than metabolic inhibitors by reducing GM-CSFRα expression, limiting STAT5 signaling, restoring regulatory markers, and rebalancing mitochondrial function.

• Tetraethylammonium Chloride for Translational K+ Research

  2026-08-27

  Tetraethylammonium chloride (TEAC) is more than a conventional potassium channel blocker. Its access to internal and external pore sites makes it a practical mechanistic probe for connecting ion conduction, vascular physiology, and translational assay design.

• Leucovorin Calcium in Gastric Cancer Assays

  2026-08-26

  Use calcium folinate as a mechanistic rescue control in methotrexate challenge studies, then test whether patient-matched stromal cells alter that response. This workflow connects folate metabolism experiments with gastric cancer assembloid screening while keeping product handling and assay interpretation practical.

• Disodium bicinchoninate: Aqueous Research Reagent

  2026-08-26

  Disodium bicinchoninate is the water-soluble sodium [2,2'-biquinoline]-4,4'-dicarboxylate salt supplied as SKU C6645. Its reported 98.00% purity, aqueous solubility, and chelating-agent profile support biochemical and molecular biology workflows, but the cited cardiovascular study does not establish it as a PDE-5 inhibitor or medical treatment.

• ddATP for DNA Synthesis Termination Workflows

  2026-08-25

  ddATP gives researchers a controllable way to stop nascent DNA selectively at positions requiring adenine incorporation, supporting sequencing, polymerase assays, and DNA-damage studies. Its use as a mechanistic perturbation is especially valuable when paired with EdU synthesis labeling and cH2A.X damage readouts in oocyte models.

• Polymer Pen Lithography for Tunable 3D SERS Arrays

  2026-08-25

  The reference study introduces a polymer pen lithography route for constructing ordered three-dimensional gold nanoparticle cluster arrays on patterned polyethylenimine scaffolds. By adjusting the lithographic pattern and array architecture, the authors obtained strong SERS enhancement together with low signal variation, offering a structurally tunable alternative to less reproducible nanoparticle aggregation methods.

• Acetoacetic Acid Sodium Salt for Reliable Assays

  2026-08-24

  This scenario-based guide explains how Acetoacetic acid sodium salt (SKU A9940) can improve control of matrix, concentration, storage, and interpretation problems in cell viability, proliferation, and cytotoxicity assays. It combines product specifications with practical decision points for energy metabolism research, diabetes metabolic imbalance, and ketone-body experiments.

• MK-8745: A Potent Aurora A Inhibitor Workflow

  2026-08-24

  MK-8745 converts Aurora A biology into a practical workflow for measuring mitotic arrest, tetraploidy, and apoptosis across cancer models. Its strong biochemical potency, defined handling requirements, and relevance to high-risk retinoblastoma research support a disciplined path from cell assays to xenograft hypotheses.

• OSMI-1: Mapping O-GlcNAc Control of Ferroptosis

  2026-08-23

  OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor for dissecting how protein O-GlcNAc modification influences iron handling, ferroptosis, and trophoblast biology. This article translates a recent HUWE1–TfR1 study into practical assay logic while emphasizing dose interpretation, controls, and toxicity limits.

• Ceftolozane/Tazobactam: Evidence and Clinical Relevance

  2026-08-22

  The reference review examines ceftolozane/tazobactam as an antipseudomonal cephalosporin and β-lactamase inhibitor combination designed to address resistant gram-negative infections. Its most important contribution is the integration of structural, microbiological, pharmacokinetic, pharmacodynamic, clinical, and safety evidence into a framework for interpreting activity against Pseudomonas aeruginosa and selected β-lactamase-producing Enterobacteriaceae.

• CTP Solution for Translational mRNA Research

  2026-08-22

  Localized mRNA delivery is creating a new translational path for bladder cancer, but therapeutic performance begins with controlled RNA synthesis. This article examines how Cytidine-5'-triphosphate supports in vitro transcription and RNA amplification workflows, connects nucleotide quality to p21 mRNA–LNP research, and explains where CTP Solution (100 mM) fits within a research-use-only development strategy.

• Large-Scale Gastruloid Arrays for Phenotype Screening

  2026-08-21

  Jan and colleagues developed an indexed magnetic microraft array that enables imaging, phenotyping, and automated recovery of individual human gastruloids at scale. The platform distinguished euploid from aneuploid gastruloids and linked altered DNA density with changes in NOG and KRT7 expression, creating a practical framework for single-structure developmental screens.

• Acetoacetic Acid Sodium Salt in Assay Design

  2026-08-20

  Acetoacetic acid sodium salt is a versatile ketone-body reagent for energy metabolism research and diabetes studies. This guide moves beyond pathway description to explain how chemical form, matrix controls, and isotope-informed validation improve assay interpretation.

7874 records 1/525 page Next 12345 下5页 Last page